Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Coffey BD"'
Autor:
Macy ME; Department of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO., Mody R; CS Mott Children's Hospital and University of Michigan, Ann Arbor, MI., Reid JM; Mayo Clinic, Rochester, MN., Piao J; University of Southern California, Los Angeles, CA., Saguilig L; University of Southern California, Los Angeles, CA., Alonzo TA; University of Southern California, Los Angeles, CA., Berg SL; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX., Fox E; St Jude Children's Research Hospital, Memphis, TN., Weigel BJ; University of Minnesota, Minneapolis, MN., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA., Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Coffey BD; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Roy-Chowdhuri S; University of Texas, MD Anderson Cancer Center, Houston, TX., Takebe N; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Seibel NL; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Parsons DW; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Sep; Vol. 8, pp. e2400418.
Autor:
Nelson MV; Children's National Hospital, Washington, DC 20010, United States., Kim A; Children's National Hospital, Washington, DC 20010, United States., Williams PM; Frederick National Laboratory for Cancer Research, Frederick MD 21701, United States., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD 20892, United States., Coffey BD; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD 20892, United States., Reid JM; Mayo Clinic, Rochester, MN 55905, United States., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA 91016, United States., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States., Berg SL; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, United States., Ramirez NC; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, United States., Jaju A; Ann and Robert H. Lurie Children's Hospital, Chicago, IL 60611, United States., Fox E; St Jude Children's Research Hospital, Memphis, TN 38105, United States., Weigel BJ; University of Minnesota/Masonic Cancer Center, Minneapolis, MD 55455, United States., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA 98105, United States., Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, United States., Takebe N; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, United States., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, United States., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States., Seibel NL; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, United States., Parsons DW; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. 723-e1093.
Autor:
Glade Bender JL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Pinkney K; Department of Hematology-Oncology, Memorial Regional Hospital/Joe Dimaggio Children's Hospital, Hollywood, FL, United States., Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Roy-Chowdhuri S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Coffey BD; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Reid JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States., Piao J; Department of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA, United States., Alonzo TA; Department of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Berg SL; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, United States., Ramirez NC; Biopathology Center, Nationwide Children's Hospital, Columbus, OH, United States., Fox E; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States., Weigel BJ; Department of Pediatrics, Hem/Onc/BMT, University of Minnesota Medical Center, Pediatric Hematology Oncology, Minneapolis, MN, United States., Hawkins DS; Department of Hematology-Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States., Mooney MM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, United States., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, United States., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Janeway KA; Department of Pediatrics, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, United States., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, United States., Parsons DW; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Jul 05; Vol. 29 (7), pp. 638-e952.
Autor:
Chi SN; Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Yi JS; Department of Pediatrics, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA., Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Roy-Chowdhuri S; Department of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Coffey BD; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Reid JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Piao J; Department of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA, USA., Alonzo TA; Department of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Berg SL; Department of Pediatrics, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA., Ramirez NC; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Jaju A; Department of Radiology, Ann and Robert H. Lurie Children's Hospital, Chicago, IL, USA., Mhlanga JC; Department of Radiology, Washington University School of Medicine, St Louis, MO, USA., Fox E; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA., Hawkins DS; Department of Hematology-Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Mooney MM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, USA., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Janeway KA; Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, USA., Parsons DW; Department of Pediatrics, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Nov 08; Vol. 115 (11), pp. 1355-1363.